BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7279697)

  • 1. Pancreatic oncofoetal antigen (POA): its frequency and localisation in humans.
    Hobbs JR; Knapp ML; Branfoot AC
    Oncodev Biol Med; 1980 Aug; 1(1):37-48. PubMed ID: 7279697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on a pancreatic oncofetal antigen (POA) in patients with pancreatic cancer].
    Hishnuma S
    Nihon Geka Gakkai Zasshi; 1986 Nov; 87(11):1449-60. PubMed ID: 3785134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pancreatic oncofetal antigen (POA) and carcinoma of the pancreas].
    Homma T; Oguchi H; Kawa S; Nagata A; Furuta S
    Gan No Rinsho; 1984 May; 30(6 Suppl):558-62. PubMed ID: 6205174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pancreatic oncofetal antigen (POA)--its characterization and the result of enzyme immunoassay].
    Homma T
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):617-22. PubMed ID: 6349543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous evaluation of a pancreas-specific antigen and a pancreatic cancer-associated antigen in pancreatic carcinoma.
    Loor R; Kuriyama M; Bodziak ML; Inaji H; Douglass HO; Berjian R; Nicolai JJ; Tytgat GN; Chu TM
    Cancer Res; 1984 Aug; 44(8):3604-7. PubMed ID: 6744282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pancreatic oncofetal antigen (POA): its characterization and application for enzyme immunoassay.
    Oguchi H; Homma T; Kawa S; Nagata A; Furuta S; Fukui H
    Cancer Detect Prev; 1984; 7(1):51-8. PubMed ID: 6367984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic significance of pancreatic antigen determination].
    Velbri S; Männiste J
    Z Gesamte Inn Med; 1980 Sep; 35(17):684-8. PubMed ID: 6162288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoperoxidase detection of pancreatic oncofetal antigen in human tissues.
    Kawa S
    Gastroenterol Jpn; 1985 Aug; 20(4):361-7. PubMed ID: 3902552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pancreatic oncofetal antigen (POA)].
    Mugitani H; Furue H; Kako M; Hirota F; Fuse K; Takahashi T; Sakamoto K; Yamada K; Suminaga M; Ezaki M; Judo R
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1737-43. PubMed ID: 6882002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pancreatic cancer-related antigen (PCAA) and pancreatic tissue antigen (PaA)--their chemical compositions, tissue localization, and clinical significance].
    Shimano T; Mori T; Maruyama H; Kitada M; Kosaki G
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):609-16. PubMed ID: 6881993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of the enzyme immunoassay for pancreatic oncofetal antigen.
    Kawa S; Homma T; Oguchi H; Nagata A; Furuta S; Usuda N; Nagata T; Fukui H
    Ann N Y Acad Sci; 1983; 417():400-9. PubMed ID: 6367597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic oncofoetal antigen in pancreatic cancer.
    Hobbs JR; Branfoot AC; Knapp ML
    Practitioner; 1980 Oct; 224(1348):1023-7. PubMed ID: 7220429
    [No Abstract]   [Full Text] [Related]  

  • 13. The diagnostic significance of the immunoglobulin A to M and A to total ratios in the pancreatoduodenal fluid of patients with benign and malignant pancreatic diseases.
    Bramis JP; Messer J; Nacchiero M; Dreiling DA
    Am J Gastroenterol; 1978 May; 69(5):565-71. PubMed ID: 356594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of pancreatic cancer by pancreatic oncofetal antigen (poa) in pure pancreatic juice.
    Nishida K; Kondo M; Jessen K; Classen M
    Hepatogastroenterology; 1981 Apr; 28(2):102-5. PubMed ID: 7216142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme immunoassay of pancreatic oncofetal antigen (POA) as a marker of pancreatic cancer.
    Nishida K; Sugiura M; Yoshikawa T; Kondo M
    Gut; 1985 May; 26(5):450-5. PubMed ID: 3888788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on an oncofetal antigen, POA.
    Gelder F; Reese C; Moossa AR; Hunter R
    Cancer; 1978 Sep; 42(3 Suppl):1635-45. PubMed ID: 101295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The significance of immunologic methods of research in several diseases of the pancreas].
    Sidorov KA; Bugrimov VG; Durov IuM
    Sov Med; 1968 Feb; 31(2):31-4. PubMed ID: 5646786
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of enzyme immunoassay for a pancreatic oncofetal antigen (POA)].
    Hishinuma S; Takami H; Shintoku J; Matsui J; Uematsu S; Baba H; Ogata Y; Abe O; Ishii T; Miyoshi K
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2217-24. PubMed ID: 6398349
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum antibodies in human pancreatic disease.
    Lendrum R; Walker G
    Gut; 1975 May; 16(5):365-71. PubMed ID: 1095452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta pathway: role in pancreas development and pancreatic disease.
    Rane SG; Lee JH; Lin HM
    Cytokine Growth Factor Rev; 2006; 17(1-2):107-19. PubMed ID: 16257256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.